M. Buffet

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

Paul Coppo, Michaël Schwarzinger, M. Buffet et al. · PLoS ONE · 2010 · 415 citations · Full text

Medicine, Hematology, Internal Medicine +9

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

Antoine Froissart, M. Buffet, Agnès Veyradier et al. · Critical Care Medicine · 2011 · 291 citations

Medicine, Hematology, Immunology +13

Diagnosing Treponema pallidum in Secondary Syphilis by PCR and Immunohistochemistry

M. Buffet, P. Grange, P. Gerhardt et al. · Journal of Investigative Dermatology · 2007 · 163 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +6

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

Y. Benhamou, C. Assié, Pierre‐Yves Boëlle et al. · Haematologica · 2012 · 155 citations · Full text

Medicine, Hematology, Internal Medicine +11

Cancer Awareness in Atypical Thrombotic Microangiopathies

Lucie Obéric, M. Buffet, Michaël Schwarzinger et al. · The Oncologist · 2009 · 94 citations · Full text

Medicine, Hematology, Oncology +16